边圆,刘海雁,高璐瑶,杨秀婷,曹盛川,韩宇,刘维康,刘湘国,夏亚楠

• 1:中国医疗保健国际交流促进会胸痛学分会
• 2:山东省医学会心肺复苏与体外生命支持多学科联合委员会
• 3:《体外膜肺氧合辅助循环崩溃高风险经导管主动脉瓣置换术技术要点专家共识》专家组
• 4:山东大学齐鲁医院

摘要(Abstract)：

经导管主动脉瓣置换术（TAVR）患者围术期发生心搏骤停、急性心力衰竭、恶性心律失常、急性肾功能衰竭等严重并发症时，应用体外膜肺氧合（ECMO）等循环辅助支持可改善患者预后。但目前对于ECMO辅助循环崩溃高风险TAVR的技术要点尚未形成系统、规范共识。为此，由中国医疗保健国际交流促进会胸痛学分会、山东省医学会心肺复苏与体外生命支持多学科联合委员会牵头组织国内急危重症、心血管内外科、医学影像、康复医学等领域的专家，梳理了国内外最新循证医学证据和重要进展，结合专家临床实践经验，共同制订了《体外膜肺氧合辅助循环崩溃高风险经导管主动脉瓣置换术技术要点专家共识》，旨在规范TAVR围术期ECMO的主要技术要点，以期使ECMO更好服务于TAVR围术期管理，进一步提高TAVR患者的手术成功率，改善患者预后。

关键词(KeyWords)： 经导管主动脉瓣置换术;主动脉瓣狭窄;体外膜肺氧合;专家共识

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金重点项目（82030059）;; 国家重点研发计划项目（2020YFC1512700）;; 山东省重点研发计划项目（2021ZLGX02）

作者(Author): 边圆,刘海雁,高璐瑶,杨秀婷,曹盛川,韩宇,刘维康,刘湘国,夏亚楠

参考文献(References)：

• [1]Davidson LJ,Davidson CJ.Transcatheter treatment of valvular heart disease:a review[J].JAMA,2021,325(24):2480-2494.DOI:10.1001/j ama.2021,2133.
• [2]Gargiulo G,Sannino A,Capodanno D,et al.Transcatheter aortic valve implantation versus surgical aortic valve replacement:a systematic review and meta-analysis[J].Ann Intern Med,2016,165(5):334-344,DOI:10.7326/M16-0060.
• [3]Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis:first human case description[J].Circulation,2002,106(24):3006-3008.DOI:10.1161/01.cir.0000047200.36165.b8.
• [4]Puri R,Chamandi C,Rodriguez-Gab ella T,et al. Future of transcatheter aortic valve implantation-evolving clinical indications[J].Nat Rev Cardiol,2018,15(1):57-65.DOI:10.103 8/nrcardio,2017,116.
• [5]Leon MB,Smith CR,Mack M,et al.Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery[J].N Engl J Med,2010,363(17):1597-1607.DOI:10.10 5 6/nejmoa1008232.
• [6]Oyetunji SO,Otto CM.Transcatheter aortic valve implantation or replacement?Valve durability in the context of patient life expectancy[J].Eur Heart J,2021,42(30):2920-2923.DOI:10.10 9 3/eurheartj/ehab 3 9 3.
• [7]Carroll JD,Mack MJ,Vemulapalli S,et al.STS-ACC TVT registry of transcatheter aortic valve replacement[J],J Am Coll Cardiol,2020,76(21):2492-2516.DOI:10.1016/j.jacc.2020.09.595.
• [8]Vahanian A,Beyersdorf F,Praz F,et al.2021 ESC/EACTS guidelines for the management of valvular heart disease:developed by the task force for the management of valvular heart disease of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)[J].Rev Esp Cardiol(Engl Ed),2022,75(6):524.DOI:10.1016/j.rec.2022.05.006.
• [9]Toff WD,Hildick-Smith D,Kovac J,et al.Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis:a randomized clinical trial[J].JAMA,2022,327(19):1875-1887.DOI:10.1001/jama.2022.5776.
• [10]Siontis GCM,Overtchouk P,Cahill TJ,et al.Transcatheter aortic valve implantation vs,surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis:an updated meta-analysis[J].Eur Heart J,2019,40(38):3143-3153.DOI:10.1093/eurheartj/ehz275.
• [11]Ratnani I,Tuazon D,Zainab A,et al.The role and impact of extracorporeal membrane oxygenation in critical care[J].Methodist Debakey Cardiovasc J,2018,14(2):110-119.DOI:10.14797/mdcj-14-2-110.
• [12]罗达,付金容,黎明江,等.ECMO辅助下TAVR术治疗低流速低压差主动脉瓣重度狭窄合并重度关闭不全1例[J].中国临床案例成果数据库,2022,4(1):E06486-E06486.DOI:10.3760/cma.j.cmcr.2022,e06486.
• [13]杨力凡,潘文志,赖浩,等.体外膜肺氧合支持下治疗重度主动脉瓣狭窄一例[J].中华心血管病杂志,2019,47(11):913-915.DOI:10.3760/cma.j.issn.0253-3758.2019.11.011.
• [14]刘洋,丁鹏,程亮,等.体外膜肺氧合辅助经导管主动脉瓣植入治疗极低射血分数值的重度主动脉瓣狭窄[J].中国体外循环杂志,2019,17(1):13-17.DOI:10.13498/j.cnki.chin.j.ecc.2019.01.04.
• [15]Banjac I,Petrovic M,Akay MH,et al.Extracorporeal membrane oxygenation as a procedural rescue strategy for transcatheter aortic valve replacement cardiac complications[J].ASAIO J,2016,62(1):el-e4.DOI:10.1097/MAT.0000000000000275.
• [16]Seco M,Forrest P,Jackson SA,et al.Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation[J].Heart Lung Circ,2014,23(10):957-962.DOI:10.1016/j.hlc.2014.05.006.
• [17]Rahhab Z,El Faquir N,Tchetche D,et al.Expanding the indications for transcatheter aortic valve implantation[J],Nat Rev Cardiol,2020,17(2):75-84.DOI:10.1038/s41569-019-0254-6.
• [18]Panoulas V,Greenough N,Sulemane S,et al.The role of mechanical circulatory support in patients with severe left ventricular impairment treated with transcatheter aortic valve implantation and percutaneous coronary intervention[J].Cardiovasc Revasc Med,2021,28S:169-175.DOI:10.1016/j.carrev.2021.03.020.
• [19]Stefanini GG,Stortecky S,Cao D,et al.Coronary artery disease severity and aortic stenosis:Clinical outcomes according to SYNTAX score in patients undergoing transeatheter aortic valve implantation[J].Eur Heart J,2014,35(37):2530-2540.DOI:10.1093/eurheartj/ehu074.
• [20]Urena M,Webb JG,Eltchaninoff H,et al.Late cardiac death in patients undergoing transcatheter aortic valve replacement:incidence and predictors of advanced heart failure and suddencardiac death[J].J Am Coll Cardiol,2015,65(5):437-448.DOI:10.1016/j.j acc.2014.11.027.
• [21]Zahn R,Gerckens U,Grube E,et al.Transcatheter aortic valve implantation:first results from a multi-centre real-world registry[J].Eur Heart J,2011,32(2):198-204.DOI:10.1093/eurheartj/ehq3 39.
• [22]国家心血管病专家委员会微创心血管外科专业委员.中国经导管主动脉瓣置入术(TAVI)多学科专家共识[J].中华胸心血管外科杂志,2018,34(12):705-712.DOI:10.3760/cma.j.issn.1001.4497.2018.12.001.
• [23]Piazza N,Wenaweser P,van Gameren M,et al.Relationship between the logistic Euro SCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the Core Valve ReValying system-a BernRotterdam Study[J].Am Heart J,2010,159(2):323-329.DOI:10.1016/j.ahj.2009.11.026.
• [24]Rosenhek R,Iung B,Tornos P,et al.ESC working group on valvular heart disease position paper:assessing the risk of interventions in patients with valvular heart disease[J].Eur Heart J,2012,33(7):822-828.DOI:10.1093/eurheartj/ehr061.
• [25]床旁超声在急诊体外膜肺氧合治疗中的应用推荐专家组.床旁超声在急诊体外膜肺氧合治疗中的应用推荐[J].中华急诊医学杂志,2020,29(12):1537-1547.DOI:10.3760/cma.j.issn.1671-0282.2020.12.006.
• [26]朱业,谢雨霁,谢明星,等.人工智能在心血管超声的应用[J].中华超声影像学杂志,2021,30(4):356-361.DOI:10.3760/cma.j.cn1311482020092900783.
• [27]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术中国专家共识(2020更新版)[J].中国介入心脏病学杂志,2020,28(6):301-309.DOI:10.3969/j.issn.1004-8812.2020.06.001.
• [28]中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识(2021版)[J].中国循环杂志,2022,37(1):12-23.DOI:10.3969/j.issn.1000-3614.2022.01.003.
• [29]Husser 0,Holzamer A,Philipp A,et al.Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation[J].Catheter Cardiovasc Interv,2013,82(4):E542-E551.DOI:10.1002/ccd,24806.
• [30]Okada T,Yoshida T,Makino S,et al.Anesthetic management of transcatheter aortic valve replacement under extracorporeal membrane oxygenation in a patient with acute decompensated heart failure:a case report[J].Kobe J Med Sci,2019,65(3):E90-E94.
• [31]Sy E,Sklar MC,Lequier L,et al.Anticoagulation practices and the prevalence of major bleeding,thrombo embolic events,and mortality in venoarterial extracorporeal membrane oxygenation:a systematic review and meta-analysis[J].J Crit Care,2017,39:87-96.DOI:10.1016/j.jcrc.2017.02.014.
• [32]Brodie D,Slutsky AS,Combes A.Extracorporeal life support for adults with respiratory failure and related indications:a review[J].JAMA,2019,322(6):557-568.DOI:10.1001/jama.2019.9302.
• [33]Jiritano F,Serraino GF,ten Cate H,et al.Platelets and extracorporeal membrane oxygenation in adult patients:a systematic review and meta-analysis[J].Intensive Care Med,2020,46(6):1154-1169.DOI:10.1007/s00134-020-06031-4.
• [34]Cahill TJ,Chen M,Hayashida K,et al.Transcatheter aortic valve implantation:current status and future perspectives[J].Eur Heart J,2018,39(28):2625-2634.DOI:10.1093/eurheartj/ehy244.
• [35]Feistritzer HJ,Kurz T,Stachel G,et al.Impact of anesthesiastrategy and valve type on clinical outcomes after transcatheter aortic valve replacement[J].J Am Coll Cardiol,2021,77(17):2204-2215.DOI:10.1016/j.jacc.2021.03.007.
• [36]Gélinas C,Fillion L,Puntillo K A,et al.Validation of the critical-care pain observation tool in adult patients[J].Am J Crit Care,2006,15(4):420-427.
• [37]Ely EW,Truman B,Shintani A,et al.Monitoring sedation status over time in ICU patients:reliability and validity of the Richmond Agitation-Sedation Scale(RASS)[J].JAMA,2003,289(22):2983-2991.DOI:10.1001/jama.289.22.2983.
• [38]Bayram Z,Dogan C,GürcüE,et al.Development of acute severe right heart failure after transcatheter aortic valve implantation in patient with left ventricle assist device-acquired aortic regurgitation[J].Turk Kardiyol Dern Ars,2020,48(5):545-551.DOI:10.5543/tkda.2020.39132.
• [39]Bian Y,Xu F.Lv RJ,et al.An early warning scoring system for the prevention of acute heart failure[J].Int J Cardiol,2015,183:111-116.DOI:10.1016/j.ijcard.2015.01.076.
• [40]Puri R,lung B,Cohen DJ,et al.TAVI or No TAVI:identifying patients unlikely to benefit from transcatheter aortie valve implantation[J].Eur Heart J,2016,37(28):2217-2225.DOI:10.10 9 3/eurheartj/ehv756.
• [41]Chakravarty T,Jilaihawi H,Doctor N,et al.Complications after transfemoral transcatheter aortic valve replacement with a balloon-expandable prosthesis:the importance of preventative measures and contingency planning[J].Catheter Cardiovasc Interv,2018,91(5):E29-E42.DOI:10.1002/ccd.24888.
• [42]Orvin I,Perl L,Landes U,et al.Percutaneous mechanical circulatory support from the collaborative multicenter mechanical unusual support in TAVI(MUST)registry[J].Catheter Cardiovasc Interv,2021,98(6):E862-E869.DOI:10.1002/ccd.29747.
• [43]Verdugo FJ,Cataldo P,Sandoval J,et al.Peripheral venoarterial extracorporeal membrane oxygenation for periprocedural cardiogenic shock during interventional cardiology[J].Rev Med Chil,2020,148(9):1295-1301.DOI:10.4067/S0034-98872020000901295.
• [44]Thomas J,Kostousov V,Teruya J.Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation[I].Semin Thromb Hemost,2018,44(1):20-29.DOI:10.1055/s-0037-1606179.
• [45]Protti A,Iapichino GE,Di Nardo M,et al.Anticoagulation management and antithrombin supplementation practice during veno-venous extracorporeal membrane oxygenation:a worldwide survey[J].Anesthesiology,2020,132(3):562-570.DOI:10.1097/ALN.0000000000003044.
• [46]Panigada M,Cucino A,Spinelli E,et al.A Randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation[J].Crit Care Med,2020,48(11):1636-1644.DOI:10.1097/CCM.0000000000004590.
• [47]中国心胸血管麻醉学会,中华医学会麻醉学分会,中国医师协会麻醉学医师分会,等.不同情况下成人体外膜肺氧合临床应用专家共识(2020版)[J].中国循环杂志,2020,35(11):1052-1063.DOI:10.3969/j.issn.1000-3614.2020.11.002.
• [48]Vranckx P,Windecker S,Welsh RC,et al.Thrombo-embolic prevention after transcatheter aortic valve implantation[J].Eur Heart J,2017,38(45):3341-3350.DOI:10.1093/eurheartj/ehx390.
• [49]司向,管向东.体外膜肺氧合抗凝管理现状和挑战[J].中华医学杂志,2022,102(25):1864-1869.DOI:10.3760/cma.j.cn112137-20220223-00373.
• [50]中国医师协会介入医师分会,中国研究型医院学会介入医学专委会.介入诊疗围手术期抗生素使用专家共识[J].介入放射学杂志,2022,31(4):319-327,DOI:10.3969/j.issn.1008-794X.2022.04.001.
• [51]张海波,孟旭,韩杰,等,危重症心脏外科患者的ECMO辅助技术与IABP、CRRT、呼吸机的相互配合治疗策略[J].中华胸心血管外科杂志,2014,30(2):71-75.DOI:10.3760/cma.j.issn.1001-4497.2014.02.003.
• [52]Hadaya J,Benharash P.Extracorporeal membrane oxygenation[J].JAMA,2020,323(24):2536.DOI:10.1001/jama.2020.9148.
• [53]Aneman A,Macdonald P.Venoarterial extracorporeal membrane oxygenation for cardiac arrest/cardiogenic shock[J].Intensive Care Med,2017,43(1):116-118.DOI:10,1007/s00134-016-4624-9.
• [54]Lefevre T.Cardiac death after TAVR:moving up a notch[J].J Am Coll Cardiol,2015,65(5):449-451.DOI:10.1016/j.jacc.2014.11.026.
• [55]Liang Y,Dhoble A,PakanatiA,et al.Catastrophic cardiac events during transcatheter aortic valve replacement[J].Can J Cardiol,2021,37(10):1522-1529.DOI:10.1016/j.cjca2021.05.002.
• [56]Schurr JW,Noubani M,Santore LA,et al.Survival and outcomes after cardiac arrest with VA-ECMO rescue therapy[J].Shock,2021,56(6):939-947.DOI:10.1097/SHK.0000000000001809.
• [57]Gass A,Palaniswamy C,Aronow WS,et al.Peripheral venoarterial extraco rporeal membrane oxygenation in combination with intra-aortic balloon counterpulsation in patients with cardiovascular compromise[J].Cardiology,2014,129(3):137-143.DOI:10.1159/000365138.
• [58]Yang F,Jia ZS,Xing JL,et al.Effects of intra-aortic balloon pump on cerebral blood flow during peripheral venoarterial extracorporeal membrane oxygenation support[J].J Transl Med,2014,12:106.DOI:10.1186/1479-5876-12-106.
• [59]Han KS,Kim SJ,Lee EJ,et al.Experience of extracorporeal cardiopulmonary resuscitation in a refractory cardiac arrest patient at the emergency department[J].Clin Cardiol,2019,42(4):459-466.DOI:10.1002/clc.23169.
• [60]李斌飞,廖小卒,程周,等.乌司他丁在体外膜肺氧合中的肝保护作用[J].南方医科大学学报,2012,32(10):1511-1512.DOI:10.3969/j.issn.1673-4254.2012.10.029.
• [61]Roh D,Park S.Brain multimodality monitoring:updated perspectives[J].Curr Neurol Neurosci Rep,2016,16(6):56.DOI:10.1007/s11910-016-0659-0.
• [62]Hemphill JC,Andrews P.De Georgia M.Multimodal monitoring and neurocritical care bioinformatics[J].Nat Rev Neurol,2011,7(8):451-460.DOI:10.1038/mneurol.2011.101.
• [63]Illum B,Odish M,Minokadeh A,et al.Evaluation,treatment,and impact of neurologic injury in adult patients on extracorporeal membrane oxygenation:a review[J].Curr Treat Options Neurol,2021,23(5):15.DOI:10,1007/s11940-021-00671-7.
• [64]Sutter R,Tisljar K,Marsch S.Acute neurologic complications during extracorporeal membrane oxygenation:a systematic review[J].Crit Care Med,2018,46(9):1506-1513.DOI:10.1097/CCM.0000000000003223.
• [65]Wong JK,Melvin AL,Joshi DJ,et al.Cannulation-related complications on Veno-Arterial extracorporeal membrane oxygenation:prevalence and effect on mortality[J].Artif Organs,2017,41(9):827-834.DOI:10.1111/aor.12880.